Aging study: MediTrain vs Worder
Official title Enhancing Attention and Wellbeing Using Digital Therapeutics
ClinicalTrials.gov ID: NCT06397469
What this study is testing
- What it's testing
- The study will find the best dose of a digital program for boosting cognition and see how factors like genetics, heart health, and race affect results.
- Who it's for
- Older adults who have mild cognitive decline or are at risk for dementia.
- What's involved
- Participants will use a digital therapy program, complete cognitive tests, and share health information during the study.
- Time commitment
- The study lasts several months and requires regular visits or online check‑ins to track progress.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 60 to 99. Healthy volunteers may be eligible.
You may be able to join if
- 60+ years old (adult)
- English language fluency
- owning a smartphone or tablet
You likely can't join if
- Under 60 years old (minor)
The study team makes the final eligibility decision.
Where it is enrolling
- San Francisco, California, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 60 years to 99 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at San Francisco, California, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.